Editorial - Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: Analysis of the SEARCH database
BERKELEY, CA (UroToday.com) - In the online edition of Urology, Dr. Steven Chang and associates from the SEARCH database report that time to first detectable ultrasensitive PSA (uPSA) identifies men with low-risk recurrence prostate cancer (CaP).
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
